Inactive Instrument

Highlights OrganiGram Holdings Inc Toronto S.E.

Equities

CA68620P1018

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Organigram Holdings Completes Underwritten Public Offering	Apr. 02	MT
Cannabis Stocks: Wedbush Notes Florida Supreme Court Approved Proposed Amendment For Adult Use Cannabis to be Placed on the 2024 General Election Ballot	Apr. 02	MT
Organigram Reports Minority Investment in Open Book Extracts; Up 8.8%	Mar. 26	MT
Organigram Up 2.2% In US Premarket After Receiving Health Canada's Final Redetermination on Jolts	Mar. 25	MT
Organigram Holdings Inc. Receives Health Canada?S Final Redetermination on Jolts	Mar. 22	CI
Organigram Notes The Standing Committee on Finance's Recommendation on Excise Duty	Feb. 28	MT
Organigram Swings to Loss in Fiscal Q1, Net Revenue Falls; Provides Outlook; Down Over 13%	Feb. 13	MT
Organigram Swings to Loss in Fiscal Q1, Net Revenue Falls; Provides Outlook	Feb. 13	MT
Organigram Holdings Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 13	CI
North American Morning Briefing : Stocks Seen -2-	Feb. 13	DJ
Organigram Brief: Compared to the prior period, net revenue decreased 16% to US$36.5 million, from $43.3 million in Q1 Fiscal 2023	Feb. 13	MT
Organigram Brief: Achieved positive Adjusted EBITDA and positive cash flow from operations of US$7.7 million	Feb. 13	MT
Organigram Holdings Reports First Shipment to Germany	Jan. 31	MT
Organigram Brief: Says Completed First Shipment to Germany, Extending its International Reach	Jan. 31	MT
Organigram Holdings Inc. Completes First Shipment to Germany as Part of Its Multi-Year Agreement with Sanity Group	Jan. 31	CI
Organigram Brief: Announced First Tranche Closing from BAT Investment	Jan. 24	MT
Organigram Holdings Secures Shareholder Approval for $124.6 Million Investment from BAT	Jan. 19	MT
Organigram Holdings Secures Shareholder Approval for $124.6 Million Investment from BAT	Jan. 19	MT
Organigram Brief: Announced Mailing of Management Info Circular in Connection with Annual General and Special Meeting To Approve $124.6 Million Investment from BAT at $3.2203/share and Creation of "Jupiter" Strategic Investment Pool	Dec. 29	MT
Organigram's Fiscal Q4 Loss Widens, Revenue Rises; Provides Fiscal 2024 Outlook; Down 5.1%	Dec. 19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights OrganiGram Holdings Inc Toronto S.E.

Equities

CA68620P1018

Highlights

Filters